Verve Therapeutics Inc.

AI Score

0

Unlock

6.18
-0.15 (-2.37%)
At close: Mar 03, 2025, 3:59 PM
6.15
-0.57%
After-hours: Mar 03, 2025, 04:47 PM EST

Verve Therapeutics Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 172.56M 206.18M 115.41M 64.33M 8.99M 2.99M
Short-Term Investments 351.72M 417.77M 439.4M 296.11M 63.12M 15.8M
Long-Term Investments n/a n/a 4.82M 5.24M 463K 235K
Other Long-Term Assets 7.92M 6.94M 585K 2.7M n/a n/a
Receivables 3.25M 5.9M 1.01M n/a n/a n/a
Inventory n/a n/a 1.00 n/a n/a n/a
Other Current Assets 15.21M 8.1M 7.34M 13.37M 1.85M 272K
Total Current Assets 542.75M 637.95M 563.16M 367.13M 73.97M 19.05M
Property-Plant & Equipment 96.73M 107.8M 110.66M 9.06M 3.98M 2.36M
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 104.64M 114.74M 116.06M 17M 4.45M 2.59M
Total Assets 647.39M 752.69M 679.22M 384.12M 78.41M 21.65M
Account Payables 4.52M 6.64M 2.42M 7.08M 36K 2.41M
Deferred Revenue 3.6M n/a 20.01M -12.99M 90K 31K
Short-Term Debt 10.44M 10.19M 23.81M 3.91M n/a n/a
Other Current Liabilities 24.34M 20.18M 8.86M 11.04M 7.19M 1.11M
Total Current Liabilities 42.91M 37.01M 35.09M 22.02M 7.32M 3.55M
Long-Term Debt 59.54M 64.72M 70.01M n/a 125.16M 35.05M
Other Long-Term Liabilities 51.54M 2.91M 3.17M 4.75M 9.72M 2.46M
Total Long-Term Liabilities 111.08M 116.18M 93.2M 4.75M 135.01M 37.65M
Total Liabilities 153.99M 153.19M 128.29M 26.77M 142.32M 41.2M
Total Debt 69.98M 74.91M 81.92M 1.96M 125.16M 35.05M
Common Stock 89K 82K 62K 49K 3K 2K
Retained Earnings -743.01M -544.3M -344.24M -186.85M -66.54M -20.83M
Comprehensive Income 428K 272K -694K -228K 8K 9K
Shareholders Equity 493.4M 599.5M 550.93M 357.35M -63.91M -19.55M
Total Investments 351.72M 417.77M 439.4M 296.11M 63.12M 15.8M